7 - What's Hot in ID + HIV

Sunday, October 19, 2025

1:30 PM - 3:15 PM US ET

Location: Ballroom (Hall B1)

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
CNE Credits: Maximum of 1.75 hours of ANCC Credit
ACPE Credits: ACPE 1.75 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 2 of PACE contact hours
CE Broker: Maximum of 2 CE broker credit hours

Moderator(s)

Yohei Doi, MD, PHD (he/him/his)

Professor of Medicine
Division of Infectious Diseases
University of Pittsburgh
Toyoake, Aichi, Japan
Aadia Rana, MD (she/her/hers)

Professor of Medicine
University of Alabama-Birmingham School of Medicine
Birmingham, AL, United States

Faculty(s)

Colleen F. Kelley, MD, MPH (she/her/hers)

Professor of Medicine
Emory University
Atlanta, GA, United States
Marina Caskey, MD

Professor of Clinical Investigation
Rockefeller University
New York, NY, United States
Patty Wright, MD (she/her/hers)

Professor, Infectious Diseases
Medicine
Vanderbilt University Medical Center
Nashville, TN, United States
DR

David Relman, MD (he/him/his)

Thomas C. and Joan M. Professor
Stanford University
Stanford, CA, United States

Disclosure(s):

Yohei Doi, MD, PHD: GSK: Advisor/Consultant; Meiji Seika Pharma: Advisor/Consultant; Shionogi: Advisor/Consultant, Honoraria

Aadia Rana, MD: No financial relationships to disclose.

Colleen F. Kelley, MD, MPH: Gilead Sciences: Grant/Research Support; GSK/ViiV Healthcare: Grant/Research Support; Moderna, Inc.: Grant/Research Support; Novavax, Inc.: Grant/Research Support

Marina Caskey, MD: GSK/ViiV Healthcare: Advisor/Consultant; Merck and Company, Inc.: Advisor/Consultant

Patty W. Wright, MD: No financial relationships to disclose.

David A. Relman, MD: Blue Willow Biologics: Stocks/Bonds (Private Company); Cantata Bio: Advisor/Consultant, Stocks/Bonds (Private Company); Inflammatix Inc.: Patent on host response markers of infection; Karius: Stocks/Bonds (Private Company); ProdermIQ: Stocks/Bonds (Private Company); Second Genome: Stocks/Bonds (Private Company); Visby Medical, Inc: Advisor/Consultant

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe new developments in the field of clinical and epidemiological sciences in HIV;
explain new research findings in basic science advances in treatment, cure and prevention of HIV and HIV pathogenesis;
discuss what is new in the field of infectious diseases using basic and clinical science.

Presentations:

1:30 PM - 1:55 PM US ET

What's Hot in HIV Basic Sciences
Speaker: Marina Caskey, MD – Rockefeller University
1:55 PM - 2:20 PM US ET

What's Hot in HIV Clinical Sciences
Speaker: Colleen F. Kelley, MD, MPH (she/her/hers) – Emory University
2:20 PM - 2:45 PM US ET

What's Hot in ID Basic Sciences
Speaker: David A. Relman, MD (he/him/his) – Stanford University
2:45 PM - 3:15 PM US ET

What's Hot in ID Clinical Sciences
Speaker: Patty W. Wright, MD (she/her/hers) – Vanderbilt University Medical Center